EZH2 inhibition sensitizes IDH1R132H mutant gliomas to histone deacetylase inhibitor. https://www.biorxiv.org/content/10.1101/2023.07.31.551045v1?med=mas
EZH2 inhibition sensitizes IDH1R132H mutant gliomas to histone deacetylase inhibitor. https://www.biorxiv.org/content/10.1101/2023.07.31.551045v1?med=mas